SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Fitch Ratings officials, previously concerned with Palomar Health’s outstanding debt, recently upgraded what had been a negative outlook to stable – citing increasing financial stability and a good market position as key drivers for the revision.
San Diego-based Human Longevity Inc. announced a multiyear agreement with Oceanside's Genentech, a member of the Roche Group, to conduct whole genome sequencing of tens of thousands of samples from Genentech.
San Diego-based Neuropore Therapies Inc., a biotechnology firm, has entered into a collaboration agreement with Belgium-based UCB S.A. to develop and commercialize products that may slow the progression of Parkinson’s disease and related disorders.
HEALTH: Strong Bipartisan Support For Nixing Controversial Levy
During the opening session of the newly-elected Congress, a bipartisan group of politicians introduced yet another measure to repeal the medical device tax.
MEDICINE: More Personal, Complete Services Sought
If it wasn’t already apparent by the flocks of twenty-somethings scanning labels in supermarkets — inquiring if the chicken is hormone-free, if the beef is grass-fed and if the produce is organic — market research has confirmed that the millennial generation is the most health-conscious to date,
BIOTECH: S.D. Has Novel Therapies for Fat Fight
Maybe it’s the beaches, bikinis and sunshine. Maybe it’s the local talent pool.
San Diego-based Obalon Therapeutics Inc., a private medical technology company, announced the completion of $30 million in financing to advance the development of their weight-loss device.
TruMed Systems Inc., a medical device company, graduated from the San Diego-based incubator EvoNexus with a $5.5 million Series B funding round, according to a recent press release.
Adamis Pharmaceuticals Corp., a San Diego-based biopharmaceutical company, raised about $10.6 million in a previously announced public offering, according to a recent company press release.
San Diego-based Ligand Pharmaceuticals Inc. announced that its partner New York-based Retrophin Inc. has received orphan drug designation from the U.S. Food and Drug Administration for Sparsentan, a drug developed to treat scar tissue in the filtering unit of the kidney.
Trovagene Inc., a San Diego molecular diagnostics company, announced that it has entered into a clinical collaboration with the University of California, San Diego's Moores Cancer Center.
San Diego-based Arcturus Therapeutics and Canadian company Precision NanoSystems announced a partnership for the manufacture of RNA medicines.
San Diego-based AMN Healthcare Services Inc., a health care staffing company, announced the completion of the previously announced acquisition of Onward Healthcare, Locum Leaders and Medefis from OGH LLC for a total purchase price of $82.5 million.
The California Legislature had an active year, adding 930 new laws that will come into effect in 2015 – many of which aim to reform the state’s health care industry. These come as the federal health care reform hits businesses in a big way this year.
BIOTECH: Firm’s Hemopurifier Makes A Top Invention List
San Diego-based Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced that the U.S. Food and Drug Administration has approved a clinical protocol to treat Ebola-infected individuals in the U.S. with the Aethlon Hemopurifier.